Evaluating the Adoption of e-prescribing in primary care

Download Report

Transcript Evaluating the Adoption of e-prescribing in primary care

1

MEASURING E-PRESCRIBING AND EMR ADOPTION IN PRIMARY CARE:

A MIXED METHODS APPROACH eHealth 2013 Gurprit K. Randhawa, BSc, MSc (c)

Agenda

2

 Background and Study Purpose  Methodology  Key Study Findings  Study Limitations  Recommendations  Conclusion  Q&A

Presenter Disclosure

Presenter:

Gurprit Randhawa 

Relationships with commercial interests:

 Nothing to disclose

Background and Purpose

4

 Poor adoption of e-prescribing tools that can boost productivity and safety 

Study Purpose:

 To examine the e-prescribing and EMR adoption by primary care physicians in Central Vancouver Island who use the same commercial EMR product  To make suggestions on improving e-prescribing adoption

Methodology

5

 Multi-method study design to compare 

The Ideal State of E-Prescribing

 Literature Review 

The Possible State of E-Prescribing

 Review of EMR user documentation and provincial conformance specifications for EMRs  Interview with an EMR vendor representative 

The Current State of E-prescribing

 Interview with physicians using e-prescribing assessment tool and an EMR Adoption Survey  Discussion group

6

Methodology (Cont.)

7

Results

10 papers 1 vendor interview 12 physician interviews 6 participants

8

Key Study Findings

9

Key Finding 1:

E-Rx Features Used by Physicians

Key Finding 1 (Cont.):

E-Rx Features Adopted by Physicians

10 Current Physician Use by E-Prescribing Feature

12 10 8 2 0 6 4

12 12 8 12 12 0 11 11 0 10 9 12 12 12 0 12 12 8 8 11 12 10 12 9 2 0 12 10 10 E-Prescribing Feature

11

Key Finding 2:

Barriers and Facilitators to E-Rx Adoption

12

5,0 4,0 3,0 2,0 1,0 0,0

Key Finding 3:

EMR Adoption  Average EMR Adoption score was 3.1/5

EMR Adoption Score by Functional Area

Overall EMR Adoption: 3.1/5

EMR Functional Area

13

Key Finding 3 (Cont.):

EMR Adoption

14

Key Finding 4:

Opportunities for Improving Adoption

E-Prescribing Opportunities

Use templates for frequently prescribed medications Review drug monographs Search for drugs by class Do full e prescribing

EMR Opportunities

Priority improvement areas: E-Prescribing and E-Referrals Use EMR for reminders, recalls and chronic disease management Create reports Capture complex care bills Use templates, patient handouts, physician supports, and integrated guidelines Improve technical capabilities Explore use of patient portal

15

Key Finding 5:

Gaps between Ideal and Possible States 

The Ideal State of E-Prescribing

 104 features in total  Patient Information, identification, and data access (4 features)  Current medications/medication history (12 features)  Medication selection (28 features)  Prescribing safety (25 features)  Patient education (1 feature)  Monitoring (4 features)  Repeat (renewal) prescribing (7 features)  Computer-user interface (5 features)  Transparency and accountability (5 features)  Security and confidentiality (7 features)  Interoperability and communication (6 features).

16

Key Finding 5 (Cont.):

Gaps between Ideal and Possible States 

The Possible State of E-Prescribing

 The EMR product met 27 of the 33 PITO e-prescribing requirements partially or fully  Generating prescriptions (1 feature)  Processing prescriptions (16 features)  Transmitting prescriptions (1 feature)  Viewing medications (2 features)  Managing renewals (1 feature)  Drug formularies (2 features)  Interaction checking (1 feature)  Medication profiles (2 features)  Reference support (1 feature)

17

Key Finding 5 (Cont.):

Gaps between Ideal and Possible States  55 of the 75 e-prescribing features from the Ideal state were not fully included in the Possible state

Ideal State of E-Prescribing Features

N = 55 N = 20

Possible State of E-Prescribing Features

N = 9

Recommendations

18

Improvements in Current State

 Use of features not yet adopted  Tailored coaching on the value of using unused features 

Improvements in Possible State

 Meet 7 additional PITO e-prescribing requirements  Consider inclusion and/or improvement of the 55 features from the Ideal State 

Improvements in Ideal State

 Include 9 features from the Possible State that were not fully included

Study Limitations

19

 EMR and E-Prescribing adoption examined only at one point in time  Study sample  Defining Possible State and Ideal State of E-Rx  E-Prescribing adoption examined using polar (yes no) questions

Conclusion

20

 Participating physicians are currently using most of the e-prescribing and EMR features  Significant improvements are needed in:  Searching for drugs by class  Checking for patient coverage  Using drug to procedure interaction checking  Using drug monographs  Several gaps between the ideal, possible, and current state of e-prescribing

Future Directions

21

 Conduct adoption evaluations at specific times following implementation  Examine impact of educational interventions on e prescribing adoption levels  Methodology: Review EMR usage logs and conduct on-site observations

Acknowledgements

22

 Thank you to CIHR-ISPR, Canada Health Infoway, and the eHealth Observatory for supporting this research.

23

THANK YOU

[email protected]

24

QUESTIONS?